2021年11月10日
Breaking News: Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.
The New York Times
Breaking News
Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.
Tuesday, November 9, 2021 2:43 PM EST
The vaccine grew out of a four-year collaboration between Moderna and the N.I.H., the government’s biomedical research agency.
But the company's patent application names several employees as the sole inventors of a crucial component of its coronavirus vaccine, excluding three government scientists.
Courtesy of The New York Times
Cambridge Dictionary Search Boxをご用意しましたので、英単語の検索にご利用ください。
Courtesy of Cambridge Dictionary
Breaking News
Moderna and the U.S. are in a patent dispute over the company's Covid vaccine, with potential consequences for future distribution and profits.
Tuesday, November 9, 2021 2:43 PM EST
The vaccine grew out of a four-year collaboration between Moderna and the N.I.H., the government’s biomedical research agency.
But the company's patent application names several employees as the sole inventors of a crucial component of its coronavirus vaccine, excluding three government scientists.
Courtesy of The New York Times
Cambridge Dictionary Search Boxをご用意しましたので、英単語の検索にご利用ください。
Courtesy of Cambridge Dictionary
【このカテゴリーの最新記事】
-
no image
-
no image
-
no image
-
no image
-
no image
この記事へのコメント
コメントを書く
この記事へのトラックバックURL
https://fanblogs.jp/tb/11105828
※ブログオーナーが承認したトラックバックのみ表示されます。
この記事へのトラックバック
